147 Results

People

  1. Schoder
    Schoder
  2. Zelenetz
    Zelenetz
  3. Noy
    Noy
  4. Moskowitz
    Moskowitz
  5. Palomba
    Palomba
  6. Horwitz
    Horwitz
  7. Hamlin
    Hamlin
  8. Kumar
    Kumar
  9. Matasar
    Matasar
  10. Moskowitz
    Moskowitz

Groups

  1. Center for Hematologic Malignancies (147)
  2. Department of Medicine (147)
  3. Hematologic Malignancies, Division of (147)
  4. Lymphoma (147)
  5. Molecular Imaging and Therapy Service (147)
  6. Radiology, Department of (147)
  7. Survivorship Research (69)
  8. Population Sciences Research Program (54)
  9. Epidemiology and Biostatistics (50)
  10. Biostatistics Service (43)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (72)
  2. Meeting Abstract (70)
  3. Research Letter (4)
  4. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (147)
  2. Department of Medicine (147)
  3. Hematologic Malignancies, Division of (147)
  4. Lymphoma (147)
  5. Molecular Imaging and Therapy Service (147)
  6. Radiology, Department of (147)

More Groups

People
  1. Heiko Schoder (117)
  2. Andrew Zelenetz (79)
  3. David Straus (62)
  4. Ariela Noy (60)
  5. Alison Moskowitz (56)
  6. Paul Hamlin (54)

More People

Years
  1. 2024 (3)
  2. 2023 (16)
  3. 2022 (9)
  4. 2021 (12)
  5. 2020 (9)
  6. 2019 (12)

More Years

Publications
  1. Blood (56)
  2. Journal of Clinical Oncology (17)
  3. Hematological Oncology (10)
  4. Journal of Nuclear Medicine (9)
  5. Annals of Oncology (5)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. American Society of Hematology (60)
  2. American Society of Clinical Oncology (17)
  3. Wiley Blackwell (14)
  4. Society of Nuclear Medicine (9)
  5. Oxford University Press (5)
  6. Taylor & Francis Group (5)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TITLE: A pilot study of 89Zr-DFO-REGN3767 anti-LAG-3 antibody positron emission tomography in patients with diffuse large B-cell lymphoma
    Meeting Abstract

    Pandit-Taskar, N.; Shutian, R.; Grkovski, M.; Schwartz, J.; Lyashchenko, S.; Cheung, K.; Uldrick, T.; Ma, D.; Giurleo, J.; Palomba, L.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schòˆder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save